Literature DB >> 19734734

ANCA-associated vasculitis following influenza vaccination: causal association or mere coincidence?

Rainer Birck1, Isabelle Kaelsch, Peter Schnuelle, Luis Felipe Flores-Suárez, Rainer Nowack.   

Abstract

Whether autoimmune or rheumatic disease may be precipitated after vaccination is controversially discussed among experts. Here we describe 4 cases of new onset or relapsing antineutrophil cytoplasmic antibodies associated vasculitis occurring in timely association with influenza vaccination. In the literature different subtypes of vasculitis have been repeatedly reported after influenza vaccination. Several trials in patients with preexisting auto-immune disease failed to indicate an increased risk for disease recurrence after influenza vaccination but these investigations might be underpowered to detect this very rare but relevant side effect. Although our report does not prove a causal association between vaccination and vasculitis, it seems possible that in rare cases vaccination might induce vasculitic disease.

Entities:  

Mesh:

Substances:

Year:  2009        PMID: 19734734     DOI: 10.1097/RHU.0b013e3181b55fe4

Source DB:  PubMed          Journal:  J Clin Rheumatol        ISSN: 1076-1608            Impact factor:   3.517


  8 in total

1.  Microscopic Polyangiitis Following mRNA COVID-19 Vaccination: A Case Report.

Authors:  Daeyoung So; Kyueng-Whan Min; Woon Yong Jung; Sang-Woong Han; Mi-Yeon Yu
Journal:  J Korean Med Sci       Date:  2022-05-16       Impact factor: 5.354

2.  Viral RNA in the influenza vaccine may have contributed to the development of ANCA-associated vasculitis in a patient following immunisation.

Authors:  Lisa S Jeffs; Jodie Nitschke; Jan Willem Cohen Tervaert; Chen Au Peh; Plinio R Hurtado
Journal:  Clin Rheumatol       Date:  2015-09-12       Impact factor: 2.980

3.  A Case of Antineutrophil Cytoplasmic Antibodies (ANCA)-Associated Vasculitis Post COVID-19 Vaccination.

Authors:  Zaki Al-Yafeai; Benjamin Joesph M Horn; William Terraccaine; Alvin Jose; Prathik Krishnan
Journal:  Cureus       Date:  2022-03-14

4.  MPO-ANCA associated vasculitis with mononeuritis multiplex following influenza vaccination.

Authors:  Stefanie Eindhoven; Jolien Levels; Margriet Huisman; Koos Ruizeveld de Winter; Virgil Dalm; Rehmat Alwani
Journal:  Allergy Asthma Clin Immunol       Date:  2017-12-13       Impact factor: 3.406

5.  Association between inactivated influenza vaccine and primary care consultations for autoimmune rheumatic disease flares: a self-controlled case series study using data from the Clinical Practice Research Datalink.

Authors:  Georgina Nakafero; Matthew J Grainge; Puja R Myles; Christian D Mallen; Weiya Zhang; Michael Doherty; Jonathan S Nguyen-Van-Tam; Abhishek Abhishek
Journal:  Ann Rheum Dis       Date:  2019-04-29       Impact factor: 19.103

Review 6.  Vaccines, adjuvants and autoimmunity.

Authors:  Luísa Eça Guimarães; Britain Baker; Carlo Perricone; Yehuda Shoenfeld
Journal:  Pharmacol Res       Date:  2015-08-12       Impact factor: 7.658

Review 7.  A flare of Still's disease following COVID-19 vaccination in a 34-year-old patient.

Authors:  Young Hun Jeon; Doo-Ho Lim; Seung Won Choi; Su Jin Choi
Journal:  Rheumatol Int       Date:  2021-11-19       Impact factor: 3.580

8.  Development of Alveolar Hemorrhage After Pfizer-BioNTech COVID-19 mRNA Vaccination in a Patient With Renal-Limited Anti-neutrophil Cytoplasmic Antibody-Associated Vasculitis: A Case Report.

Authors:  Ken Nishioka; Shintaro Yamaguchi; Itaru Yasuda; Norifumi Yoshimoto; Daiki Kojima; Kenji Kaneko; Mitsuhiro Aso; Tomoki Nagasaka; Eriko Yoshida; Kiyotaka Uchiyama; Takaya Tajima; Jun Yoshino; Tadashi Yoshida; Takeshi Kanda; Hiroshi Itoh
Journal:  Front Med (Lausanne)       Date:  2022-04-08
  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.